Antimicrobial Susceptibility Testing Market Analysis | CMI - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Antimicrobial Susceptibility Testing Market Analysis | CMI

Description:

Read here the latest updates on the Antimicrobial Susceptibility Testing Market Analysis published by CMI team – PowerPoint PPT presentation

Number of Views:1

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Antimicrobial Susceptibility Testing Market Analysis | CMI


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
ANALYSIS
  • Antimicrobial Susceptibility Testing Market, By
    Product Type (Manual Antimicrobial Susceptibility
    Testing Products Susceptibility Testing Disks,
    Mic Strips, and Susceptibility Plates, Automated
    Laboratory Instruments, and Consumables), By
    Application (Antibacterial, Antifungal,
    Anti-parasitic and Antiviral), By Method (Disk
    Diffusion, Rapid Automated AST, Broth Dilution,
    Gradient Diffusion, and Genotypic Methods), By
    End User (Hospitals, Pathology/Diagnostic
    Laboratories, Research and Academic Institutes,
    Pharmaceutical and Biotechnology Companies, and
    Contract Research Organizations), and By Region
    (North America, Latin America, Europe, Asia
    Pacific, Middle East, and Africa) - Size, Share,
    Outlook, and Opportunity Analysis, 2018 2026

3
  • The global Antimicrobial Susceptibility Testing
    Market size was valued at US 2.65 billion in
    2017 and is expected to witness a CAGR of 6.2
    over the forecast period (2018 2026).

4
Global Antimicrobial Susceptibility Testing
Market Share () Analysis, By Product Type, 2017
5
Market Drivers
  • Emergence of Multidrug Resistance Worldwide Is
    Expected To Drive the Antimicrobial
    Susceptibility Testing Market Revenue
  • Resistance among various microbial species to
    different antimicrobial drugs have emerged as a
    major cause of public health threat. According to
    World Health Organization (WHO), these resistant
    microorganisms such as bacteria, fungi, viruses,
    and parasites are able to combat attack by
    antimicrobial drugs, which leads to ineffective
    treatment resulting in persistence and spreading
    of infections.
  • Increasing number of multidrug resistance cases
    in tuberculosis (TB), malaria, HIV, influenza,
    and others among the global population is
    expected to result in increasing adoption of
    antimicrobial susceptibility testing to reduce
    the resistance exposure during the forecast
    period. For instance, according to the WHO, in
    2016, an estimated 490,000 people worldwide
    developed MDR-TB. The countries with the largest
    numbers of MDR/RR-TB cases were China, India and
    the Russian Federation.
  • Moreover, development of genotypic-based methods
    offering rapid and accurate detection or
    confirmation of antimicrobial resistance is
    expected to drive the market growth. For
    instance, the Accelerate ID/AST System or ID/AST
    System (Accelerate) aims to reduce the turnaround
    time by using genetic methods. The device can
    identify infectious pathogens in a matter of
    hours instead of days, reducing diagnostic time
    by 30 to 50 hours.

6
Antimicrobial Susceptibility Testing Market
Restraints
  • Stringent government regulations is the major
    restraining factor for the antimicrobial
    susceptibility testing market growth. Regulatory
    procedures creates barrier to AST development, as
    clinical validation and trials are lengthy and
    often too costly for small-sized or medium-sized
    enterprises or organizations.
  • For instance, in the U.S., a manufacturer who
    intends to market a device of generic type must
    conform to the general controls of Section
    513(a)(1)(B) of the Federal Food, Drug and
    Cosmetic Act, address the risks to health
    associated with the AST system, and obtain a
    substantial equivalence assessment from the FDA.

7
Antimicrobial Susceptibility Testing Market -
Regional Insights
  • On the basis of region, the global antimicrobial
    susceptibility testing market is segmented into
    North America, Latin America, Europe, Asia
    Pacific, Middle East, and Africa. North America
    is expected to be the most lucrative region in
    the antimicrobial susceptibility testing market
    in 2017 due to the emergence of a multidrug
    resistant strain of Salmonella in the U.S. For
    instance, according to the Centers for Disease
    Control and Prevention (CDC), September 2018,
    around two million people are infected with
    antibiotic-resistant bacteria in the U.S.
    annually and around 23,000 people die as a
    result. Moreover, government agencies in the U.S.
    have taken steps to prevent and control
    antibiotic resistance, which is expected to
    increase the adoption of antimicrobial
    susceptibility testing in the country.
  • Asia Pacific antimicrobial susceptibility testing
    market revenue is expected to foresee significant
    growth over the forecast period due to high
    prevalence of microbial infections and increasing
    consumption of antibiotics, eventually developing
    resistance among the population. According to a
    WHO report, in 2014, multidrug-resistant
    tuberculosis rates were high in India and
    treatment for the disease is generally limited.

8
Global Antimicrobial Susceptibility Testing
Market Value (US Mn) Y-o-Y Growth ()
9
Key Players
  • Key players operating in the global antimicrobial
    susceptibility testing market include bioMérieux
    S.A., HiMedia Laboratories, Alifax Holding
    S.p.A., Creative Diagnostics, Resistell AG,
    Danaher Corporation, Becton, Dickinson and
    Company, Thermo Fisher Scientific Inc., Merck
    KGaA, and Bio-Rad Laboratories, Inc.

10
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//www.coherentmarketinsights.com
    /market-insight/antimicrobial-susceptibility-testi
    ng-market-2449

11
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

12
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

13
  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com